Skip to main content

Arizona Philanthropies Contribute $45M to Create Center for Personalized Dx, Recruit Hartwell to Lead Effort

NEW YORK (GenomeWeb News) - Two philanthropies in Arizona have pledged $45 million to create a center for personalized diagnostics based on the genomics, proteomics, and bioinformatics capabilities at the Translational Genomics Research Institute and Arizona State University’s Biodesign Institute.
The Virginia G. Piper Charitable Trust will contribute $35 million and the Flinn Foundation will chip in $10 million to support the initiative, called the Partnership for Personalized Medicine.
Lee Hartwell, director of Fred Hutchinson Cancer Research Center, will lead the initiative. While retaining his post at the Hutch, he will chair the partnership’s executive committee, which includes George Poste, director of ASU’s Biodesign Institute, and Jeff Trent, president and scientific director of TGen.
The funds will support the creation of the Virginia G. Piper Center for Personalized Diagnostics, a collaboration between TGen and the Biodesign Institute, which will each contribute “significant laboratory space” to the center.
The donations will also fund “an industrial scale, high-throughput proteomics production facility” that will rely on expertise at TGen and the Biodesign Institute in the areas of computing, proteomics, and robotics.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.